Commentary: The bipolar affective disorder: Lithium/anticonvulsant evaluation (BALANCE) study

Bipolar Disorders

Volumn 12, Issue 7, 2010, Pages 669-672

  Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BALANCE trial; Bipolar disorder; Lithium; Long term treatment; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROIC ACID;

BIPOLAR I DISORDER; CLINICAL EVALUATION; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; LITHIUM CHLORIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VALPROIC ACID;

EID: 78049523009     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00860.x     Document Type: Note

References (12)

1. Baldessarini RJ, Tarazi FI. Treatments for psychiatric disorders. In: Brunton LL, Lazo JS, Parker KL eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edition. New York: McGraw-Hill Press, 2005: 429-500.
2. Calabrese JR, Goldberg JF, Ketter TA et al. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry 2006; 59: 1061-1064.
3. Soares-Weiser K, Bravo-Vergel Y, Beynon S et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 2007; 11: 1-206.
4. Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000; 61: 13-22.
5. Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry: The Comprehensive Guide. London: Taylor & Francis, 2006.
6. Baldessarini RJ, Tondo L, Lepri B. Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis. J Clin Psychopharmacol 2010; 30: 72-75.
7. Centorrino F, Ventriglio A, Vincenti A et al. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Hum Psychopharmacol 2010; 25: 179-186.
8. Baldessarini RJ, Tondo L. Lithium and suicidal risk. Bipolar Disord 2008; 10: 114-115.
9. Baldessarini RJ, Tondo L. Meta-analytic comparison of antisuicidal effects of lithium versus anticonvulsants. Pharmacopsychiatry 2009; 42: 72-75.
10. Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-395.
11. Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. Bipolar depression: overview and commentary. Harv Rev Psychiatry 2010; 18: 143-157.
12. Baldessarini RJ, Henk HJ, Sklar AR et al. Use of psychotropic medicines in bipolar disorder patients in the United States. Psychiatr Serv 2008; 59: 1175-1183.